Metabolite identification of a new antitumor agent icotinib in rats using liquid chromatography/tandem mass spectrometry
文献类型:期刊论文
作者 | Guan, Zhongmin1,3; Chen, Xiaoyan1![]() ![]() |
刊名 | RAPID COMMUNICATIONS IN MASS SPECTROMETRY
![]() |
出版日期 | 2008-07 |
卷号 | 22期号:14页码:2176-2184 |
ISSN号 | 0951-4198 |
DOI | 10.1002/rcm.3599 |
文献子类 | Article |
英文摘要 | Icotinib, 4-[(3-ethynylphenyl)amino]-6,7-benzo-12-crown-4-quinazoline, is a new antitumor agent. The metabolic pathway of icotinib in rats was studied using liquid chromatography/tandem mass spectrometry (LC/MSn) analysis. Full scan and selected ion monitoring modes were used to profile the possible metabolites of icotinib in rat urine, feces and bile samples. Four phase I metabolites (M1-M4) and two phase II metabolites (M5, M6) were detected and characterized. Multiple-stage mass spectrometry and nuclear magnetic resonance (NMR) spectrometry were employed to elucidate structures of metabolites. Icotinib was metabolized to open the crown ether ring to form the main phase I metabolites. During metabolism, a reactive metabolite was formed. Using semicarbazide as a trapping agent, an intermediate arising from opening of the crown ether ring was detected as an aldehyde product by LC/MS/MS. These data indicated that ring opening of the crown ether was triggered by hydroxylation at the 8 ''-position of the ring to form a hemiacetal intermediate, which was further oxidized or reduced. Finally, the metabolic pathway of icotinib in rats was proposed. Copyright (C) 2008 John Wiley & Sons, Ltd. |
WOS关键词 | GROWTH-FACTOR RECEPTOR ; CANCER ; GEFITINIB |
WOS研究方向 | Biochemistry & Molecular Biology ; Chemistry ; Spectroscopy |
语种 | 英语 |
WOS记录号 | WOS:000257863500004 |
出版者 | JOHN WILEY & SONS LTD |
源URL | [http://119.78.100.183/handle/2S10ELR8/272884] ![]() |
专题 | 上海药物代谢研究中心 |
通讯作者 | Zhong, Dafang |
作者单位 | 1.Chinese Acad Sci, Shanghai Inst Mat Med, Shanghai 201203, Peoples R China; 2.Zhejiang Bata Pharma Inc, Hangzhou 310004, Zhejiang, Peoples R China 3.Shenyang Pharmaceut Univ, Lab Drug Metab & Pharmacokinet, Shenyang 110016, Peoples R China; |
推荐引用方式 GB/T 7714 | Guan, Zhongmin,Chen, Xiaoyan,Wang, Yinxiang,et al. Metabolite identification of a new antitumor agent icotinib in rats using liquid chromatography/tandem mass spectrometry[J]. RAPID COMMUNICATIONS IN MASS SPECTROMETRY,2008,22(14):2176-2184. |
APA | Guan, Zhongmin,Chen, Xiaoyan,Wang, Yinxiang,&Zhong, Dafang.(2008).Metabolite identification of a new antitumor agent icotinib in rats using liquid chromatography/tandem mass spectrometry.RAPID COMMUNICATIONS IN MASS SPECTROMETRY,22(14),2176-2184. |
MLA | Guan, Zhongmin,et al."Metabolite identification of a new antitumor agent icotinib in rats using liquid chromatography/tandem mass spectrometry".RAPID COMMUNICATIONS IN MASS SPECTROMETRY 22.14(2008):2176-2184. |
入库方式: OAI收割
来源:上海药物研究所
浏览0
下载0
收藏0
其他版本
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。